RE: Prem9 Mar 2022 10:45
Acker - have to be honest and say that I wasn't impressed with the interview and, for me, exposes GR's flaws. We discover that the DFS was going to be delayed (why has he not been candid about this before?) and that this investment simply brings the DFS back to the Q3 target.. although we had to get the GR squirm before we got that info. We discover that the remaining budget for the DFS was just under $5m when the last published estimate for the whole DFS was just under $6m. So, in the last year, GR seems to have only spent $1m on the DFS??!!??
We don't get any real info about what the deal means for the EPO area and Rb doesn't get a mention.
Does this fill me with confidence that the £12m will be well spent and that he'll start hitting targets? Even with the Chinese on board, I have to say that I'm not convinced now despite my optimism of yesterday and this morning.
On paper, for shareholders, it seems a better choice to retain as much of Prem at this stage as possible but, for that option to be the right option, we need to be hitting dates and delivering. In reality, I think that there's a real risk that we don't see the progress that we need to see and that this route will ultimately be less rewarding for shareholders.
Sorry to put a damper on what should be a good day but I'm holding out for a hostile offer!
If we don't get that in the next 2 weeks then I think the sp will struggle to move from it's current level (and may drift) until we get a RUS (no mention of that either).